To enhance obesity therapy in the pediatric population, more research is required to examine the dynamics of GIP and GLP-1 production relative to Tanner stages and the long-term impacts on muscle development, bone density, and sexual maturation. This evidence concerns the gene GIP and obesity due to melanocortin 4 receptor deficiency.